Well, it won’t be this Thursday. In the cc from January, they mentioned the fact that this is a rolling review with the non clinical part being completed in January and the clinical part due by q2 of this year. So at face value, the non clinical part has probably been submitted but not the clinical piece..also, with NP saying the rest of the business has been slowed down to finish all the cd12 work, that q2 date may slip a bit